Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
At week 20, the change from baseline in HbA1c in patients treated with sitagliptin (N=107) was -0.23% compared to 0.09% in patients treated with placebo (N=113), a difference of -0.33% (95% CI: -0.70, 0.05)
It has been FDA-approved since 2014 and produced average weight loss of 5-8% of body weight in clinical trials
Reflujo o ardor
Approved by the FDA, this pill allows for daily intake without injections, providing the same benefits as its injectable counterpart
US$ 23.11
US$ 25.24
US$ 25.23
